tiprankstipranks
GRI Bio (GRI)
NASDAQ:GRI
US Market

GRI Bio (GRI) Financial Statements

88 Followers

GRI Bio Financial Overview

GRI Bio's market cap is currently ―. The company's EPS TTM is $-26.718; its P/E ratio is -0.02; GRI Bio is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -1.89M$ -6.87M$ -2.41M$ -1.49M$ -1.40M
EBITDA$ -1.87M$ -4.74M$ -2.41M$ -1.49M$ -1.24M
Net Income Common Stockholders$ -1.89M$ -6.75M$ -2.40M$ -1.58M$ -1.03M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.09M$ 4.80M$ 1.67M$ 3.78M$ 5.15M
Total Assets$ 4.59M$ 5.64M$ 2.10M$ 4.15M$ 5.57M
Total Debt$ 152.00K$ 41.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -3.94M$ -4.76M$ -1.67M$ -3.78M$ -5.15M
Total Liabilities$ 1.79M$ 1.60M$ 1.88M$ 1.81M$ 2.11M
Stockholders Equity$ 2.80M$ 4.04M$ 216.00K$ 2.34M$ 3.46M
Cash Flow-
Free Cash Flow$ -2.20M$ -11.00K$ -2.12M$ -1.37M$ -1.85M
Operating Cash Flow$ -2.20M$ -3.00K$ -2.12M$ -1.37M$ -1.85M
Investing Cash Flow-$ -8.00K-$ 420.00K$ 1.33M
Financing Cash Flow$ 4.49M$ 6.92M--$ 31.00K
Currency in USD

GRI Bio Earnings and Revenue History

GRI Bio Debt to Assets

GRI Bio Cash Flow

GRI Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis